Our data above suggested that KDM5C activates estrogen/ERα‐target gene independent on its enzymatic activity, while represses type I IFNs and ISGs in an enzymatic‐dependent manner, with both are beneficial for breast cancer cell growth and tumorigenesis. The gene discussed is ESR1; the disease is breast carcinoma.